Crossmark

Plasma Aβ42/40 Ratio Detects Early Stages of Alzheimer's Disease and Correlates with CSF and Neuroimaging Biomarkers in the AB255 Study

Crossref DOI link: https://doi.org/10.14283/jpad.2018.41

Published Print: 2019-01

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Pérez-Grijalba, V.

Romero, J.

Pesini, Pedro

Sarasa, L.

Monleón, I.

San-José, I.

Arbizu, J.

Martínez-Lage, P.

Munuera, J.

Ruiz, A.

Tárraga, L.

Boada, M.

Sarasa, M.
License Information

Text and Data Mining valid from 2019-01-01

Text and Data Mining valid from 2019-01-01

Version of Record valid from 2024-09-26
More Information

This article is maintained by: Elsevier

Article Title: Plasma Aβ42/40 Ratio Detects Early Stages of Alzheimer's Disease and Correlates with CSF and Neuroimaging Biomarkers in the AB255 Study

Journal Title: The Journal of Prevention of Alzheimer's Disease

CrossRef DOI link to publisher maintained version: https://doi.org/10.14283/jpad.2018.41

Content Type: article

Copyright: Copyright © 2018 THE AUTHORS. Published by Elsevier Masson SAS on behalf of SERDI Publisher. Published by Elsevier Masson SAS